Hepatitis C recurrence after liver transplantation

Acta Gastro-Enterologica Belgica

Volumn 62, Issue 4, 1999, Pages 428-431

  Bourgeois, N ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Hepatitis C; Immunosuppression; Interferon; Liver; Liver transplantation; Recurrent hepatitis C; Rejection; Retransplantation; Ribavirin; Steroids

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RIBAVIRIN; TACROLIMUS; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIBIOTIC THERAPY; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DRUG MEGADOSE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NEUTROPENIA; RECURRENT INFECTION; REOPERATION; THROMBOCYTOPENIA; VIREMIA;

ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; RECURRENCE; VIREMIA;

EID: 0033382898     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (62)

1. WRIGHT T.L., DONEGAN E., HSU H.H. et al. Recurrent and acquired hepatitis C viral infection in transplant recipients. Gastroenterology, 1992, 103 : 317-322.
2. FERAY C., SAMUEL D., THIERS V. et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J. Clin. Invest., 1992, 89 : 1361-1365.
3. POTERUCHA J.J., RAKELA J., LUMENG L. et al. Diagnosis of hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction. Hepatology, 1992, 15 : 42-45.
4. MATEO R., DEMETRIS A.J., SICO E. et al. Early detection of de novo hepatitis C infection after liver transplantation by reverse transcriptase polymerase chain reaction. Surgery, 1999, 114 : 442-448.
5. MARZANO A, SMEDILE A., ABATE M. et al. Hepatitis type C after orthotopic liver transplantation : reinfection and disease recurrence. J. Hepatol., 1994, 21 : 961-965.
6. SALLIE R., COHEN A.T., TIBBS C.J. et al. Recurrence of hepatitis C following orthotopic liver transplantation : a polymerase chain reaction and histological study. J. Hepatol., 1994, 21 : 536-542.
7. GANE E.J., PORTMANN B.C., NAOUMOV M.V. et al. Long-term outcome of hepatitis C infection after liver transplantation. N. Engl. J. Med., 1996, 334 : 815-820.
8. BOKER K.H.V., DALLEY G., BAHR M.J. et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology, 1997, 25 : 203-210.
9. SHEINER P.A., SCHWARTZ M.E., MOR E. et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after liver transplantation. Hepatology, 1995, 21 : 30-34.
10. FERAY C., GIGOU M., SAMUEL D. et al. The course of hepatitis C virus infection after liver transplantation. Hepatology, 1994, 20: 1137-1143.
11. CHAZOUILLÈRES O., KIM M., COOMBS C. et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology, 1994, 106 : 994-999.
12. DUVOUX C., PAWLOTSKY J.M., CHERQUI D. et al. Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. Transplantation, 1995, 60 : 457-461.
13. GANE E.J., NAOUMOV M.V., QUIAN K. et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology, 1996, 11 : 167-179.
14. GRETCH D.R., BACCHI C., COREY L. et al. Persistent hepatitis C viral infection after liver transplantation : clinical and virological features. Hepatology, 1995, 22 : 1-9.
15. COLLIER J., HEATHCOTE J. Hepatitis C viral infection in the immunosuppressed patient. Hepatology, 1998, 27 : 2-6.
16. SHIFFMAN L., CONTOS M.J., LUKETIC V.A. et al. Biochemical and histological evaluation of recurrent hepatitis C following orthotopic liver transplantation. Transplantation, 1994, 57 : 526-532.
17. GROTTOLA V.E., BUTTAFOCO P., MERIGHI A.L. et al. Long-term follow-up of hepatitis C virus infection in liver transplant patients. Clin. Transplant., 1995, 9 : 160-164.
18. SCHLUGER L.K., SHEINER P.A., THUNG S.N. et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology, 1996, 23 : 971-976.
19. DICKSON R.D., CALDWELL S.H., ISHITANI M.B, et al. Clinical and histological patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation, 1996, 63 : 1419-1423.
20. CHARLTON M.R., SEABERG E.C., WIESNER R. et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology, 1998, 28 : 823-830.
21. FERAY C., GIFOU M., SAMUEL D. et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology, 1995, 108 : 1088-1096.
22. FUKUMOTO T., BERG T., KU Y. et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation : evidence for rapid turnover of serum virions. Hepatology, 1996, 24 : 1351-1354.
23. MARTINO V., SAURINI F., SAMUEL D. et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology, 1997, 26 : 1343-1350.
24. VARGA V., KRAWCZINSKI K., CASTELL L. et al. Recurrent hepatitis C virus infection after liver transplantation : immunohistochemical assessment of the viral antigen. Liver Transplant Surg, 1998, 4 : 320-327.
25. BELLI L.S., SILINI E., ALBERTI A. et al. Hepatitis C virus genotypes, hepatitis, and hepatitis C recurrence after liver transplantation. Liver Transplant Surg., 1996, 2 : 200-205.
26. ZHOU S., TERRAULT N.A., FERREL L. et al. Severity of liver disease in liver transplant recipients with hepatitis C virus infection : relationship to genotype and level of viremia. Hepatology. 1996, 24 : 1041-1046.
27. GORDON F.D., POTERUCHA J.J., GERMER J. et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation, 1997, 63 : 1419-1423.
28. GAYOWSKI T., SINGH N., MARINO I.R. et al. Hepatitis C virus genotypes in liver transplant recipients : impact on posttransplant recurrence, infections, response to interferon alpha therapy and outcome. Transplantation, 1997, 64 : 422-426.
29. PHILIPPE G., DUCOS J., MONDAIN A. et al. Hepatitis C virus genotypes of hepatitis C virus transplant recipients : relationship with severity of histological recurrence and implication in the pathogenesis of hepatitis C virus infection. Liver Transplant Surg, 1997, 3 : 501-505.
30. BERENGUER M., TERRAULT N.A., PIATAK M. et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology, 1996, 111 : 1569-1575.
31. HUANG E., WHRIGHT T.L., LAKE J. et al. Hepatitis B and C coinfections and persistent hepatitis B infections : clinical outcome and liver pathology after transplantation. Hepatology, 1996, 23 : 396-404.
32. FONG T.L., VALINLUCK S., GOVINDARAJAN F. et al. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology, 1994, 107 :, 196-199.
33. PAPATHEODIRIDIS G.V., ANDREW D., CLEWLEY G. et al. HCV viremia after liver transplantation for HCV cirrhosis : relation to type of immunosuppression. Hepatology, 1998, 28 (suppl) : 462A (abstract).
34. BERENGUER M., PRIETO M., CORDOBA J. et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation : association with treatment of rejection. J. Hepatol., 1998, 28 : 756-763.
35. FREEMAN R., TRAN S., LEE Y. et al. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation, 1996, 61 : 542-546.
36. ROSEN H.R., SHACKLETON C.R., HIGA L. et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am. J. Gastroenterol., 1997, 92 : 1453-1457.
37. CASAVILLA A., MATEO R., RAKELA J. et al. Impact of hepatitis C virus (HCV) infection on survival following primary liver transplantation under FK506. Hepatology, 1994, 20 : 133 (abstract).
38. JOHNSON M.W., WASHBURN W.K., FREEMAN R.B. et al. Hepatitis C viral infection in liver transplantation. Arch. Surg., 1996, 131 : 284-291.
39. PAPATHEODORIDIS G.V., DHILLON A.P., DAVIES S. et al. Predictive factors of histological outcome in post-transplant HCV infection. Hepatology, 1998, 28 (suppl) : 260A (abstract).
40. FRIZELL E., ABRAHAM A., DOOLITTLE M. et al. FK506 enhances fibrogenesis in in vitro and in vivo models for liver fibrosis in rats. Gastroenterology, 1994, 107 : 492-498.
41. KHANNA A., LI B., SHARMA V.K. et al. Immunoregulatory and fibrogenetic activities of cyclosporin : an unifying hypothesis based on transforming growth factor beta expression. Transplant Proc., 1996, 28 : 2015-2018.
42. CHANG K.M., REHERMANN B., CHISARI F.V. Immunopathology of hepatitis C. Semin. Immunopathol., 1997, 19 : 57-68.
43. GRÜBER A., LUNBERG L., BJORKHOLM M. Reactivation of hepatitis C after withdrawal of immunosuppressive therapy. J. Intern. Med., 1993, 234 : 223-225.
44. EVERSON J.T. I favour early steroid withdrawal in liver transplantation. ILTS course : "Hepatic allograft rejection and evolving immunosuppressive strategies", Chicago, 1998.
45. BRAUN F., LORF T., OELLERICH M. et al. Liver transplantation without steroids. Hepatology, 1998, 28 (suppl) : 263A (abstract).
46. BELLI L., DE CARLIS L., RONDINARA G. et al. Early cyclosporine monotherapy in liver transplantation : a 5-year follow-up of a prospective randomized trial. Hepatology, 1998, 27 : 1524-1529.
47. HOOFNAGLE J.H., DE BISCEGLIE A.M. The treatment of chronic viral hepatitis. N. Engl. J. Med., 1997, 336 : 347-356.
48. WRIGHT H.I., GAVALER J.S., VAN THIEL D.H. Preliminary experience with alpha 2b interferon therapy of viral hepatitis in liver allograft recipients. Transplantation, 1992, 53 : 121-124.
49. GANE E.J., LO S.K., RIORDAN S.M. et al. A randomized study comparing Ribavirin and Interferon alpha monotherapy for hepatitis C recurrence after liver transplantation. Hepatology, 1998, 27 : 1403-1089.
50. FERAY C., SAMUEL D., GIGOU M. et al. An open trial of Interferon alpha recombinant for hepatitis C after liver transplantation. Hepatology, 1995, 22 : 1084-1089.
51. CATTRAL M.S., KRAKDEN M., WANLESS I.R. et al. A pilot study of Ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation, 1996, 61 : 1483-1488.
52. BIZOLLON T., PALAZZO U., DUCERF C. et al. Pilot study of the combination of Interferon alpha and Ribavirin as therapy of recurrent hepatitis C after LT. Hepatology, 1997, 26 : 501-504.
53. DODSON SF., ARRAYA V., BALAN V. et al. Trial of Ribavirin and alpha Interferon for the treatment of hepatitis C infection after liver transplantation. Liver Transplant Surg., 1997, 3 : C66 (abstract).
54. MAZZAFERO V., REGALIA E., PULVIRENTI A. et al. Prophylaxis against HCV recurrence after liver transplantation : effect of Interferon and Ribavirin combination. Transpl. Proc., 1997, 29 : 519-521.
55. DODSON S., ISSA S., BONHAM A. Liver transplantation for chronic viral hepatitis. In : "Surgical Clinics of North America ; liver transplantation : current management", 1999, 79 : 131-145.
56. SHEINER P.A., SCHLUGER L.K., EMRE S. et al. Retransplantation for recurrent hepatitis C. Liver Transplant Surg., 1997, 3 : 130-136.
57. FERAY C., HABSANNE A., SAMUEL D. et al. Poor prognosis of patients retransplantated for recurrent liver disease due to hepatitis C virus. Hepatology, 1995, 22 : 135A (abstract).
58. CASAVILLA F.A., LEE R., LIM J. et al. Outcome of liver retransplantation for recurrent hepatitis C infection. Hepatology, 1995, 22 : 153A (abstract).
59. GHOBRIAL R.M., COLQUHOUN S., ROSEN M. et al. Result analysis of retransplantation for hepatitis C. Hepatology, 1997, 26 : 177A (abstract).
60. SHEINER P.A., MOR E., SCHWARTZ M.E. et al. Use of hepatitis C-positive donors in liver transplantation. Transplant Proc., 1993, 25 : 3071.
61. MULLIGAN D.C., GOLDSTEIN R.M., CRIPPIN J.S. et al. Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplant Proc., 1995, 27 : 1024-1025.
62. LASKUS T., WANG L.F., RAKELA J. et al. Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology, 1996, 220 : 171-176.